Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: A randomised controlled trial in Western European outpatient settings

Henk Rigter, Craig E. Henderson, Isidore Pelc, Peter Tossmann, Olivier Phan, Vincent Hendriks, Michael Schaub, Cynthia L Rowe

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Noticing a lack of evidence-based programmes for treating adolescents heavily using cannabis in Europe, government representatives from Belgium, France, Germany, The Netherlands, and Switzerland decided to have U.S.-developed multidimensional family therapy (MDFT) tested in their countries in a trans-national trial, called the International Need for Cannabis Treatment (INCANT) study. Methods: INCANT was a 2 (treatment condition) × 5 (time) repeated measures intent-to-treat randomised effectiveness trial comparing MDFT to Individual Psychotherapy (IP). Data were gathered at baseline and 3, 6, 9 and 12 months thereafter. Study participants were recruited at outpatient secondary level addiction, youth, and forensic care clinics in Brussels, Berlin, Paris, The Hague, and Geneva. Participants were adolescents from 13 through 18 years of age with a recent cannabis use disorder. 85% were boys; 40% were of foreign descent. One-third had been arrested for a criminal offence in the past 3 months. Three primary outcomes were assessed: (1) treatment retention, (2) prevalence of cannabis use disorder and (3) 90-day frequency of cannabis consumption. Results: Positive outcomes were found in both the MDFT and IP conditions. MDFT outperformed IP on the measures of treatment retention (p<0.001) and prevalence of cannabis dependence (p=0.015). MDFT reduced the number of cannabis consumption days more than IP in a subgroup of adolescents reporting more frequent cannabis use (p=0.002). Conclusions: Cannabis use disorder was responsive to treatment. MDFT exceeded IP in decreasing the prevalence of cannabis dependence. MDFT is applicable in Western European outpatient settings, and may show moderately greater benefits than IP in youth with more severe substance use.

Original languageEnglish
Pages (from-to)85-93
Number of pages9
JournalDrug and Alcohol Dependence
Volume130
Issue number1-3
DOIs
StatePublished - Jun 1 2013

Fingerprint

Marijuana Abuse
Family Therapy
Cannabis
Outpatients
Randomized Controlled Trials
Psychotherapy
Therapeutics
Belgium
Paris
Berlin
Switzerland
Netherlands
France
Germany

Keywords

  • Adolescents
  • Cannabis dependence
  • Multi-site treatment trial
  • Multidimensional family therapy
  • Treatment retention

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Multidimensional family therapy lowers the rate of cannabis dependence in adolescents : A randomised controlled trial in Western European outpatient settings. / Rigter, Henk; Henderson, Craig E.; Pelc, Isidore; Tossmann, Peter; Phan, Olivier; Hendriks, Vincent; Schaub, Michael; Rowe, Cynthia L.

In: Drug and Alcohol Dependence, Vol. 130, No. 1-3, 01.06.2013, p. 85-93.

Research output: Contribution to journalArticle

Rigter, Henk ; Henderson, Craig E. ; Pelc, Isidore ; Tossmann, Peter ; Phan, Olivier ; Hendriks, Vincent ; Schaub, Michael ; Rowe, Cynthia L. / Multidimensional family therapy lowers the rate of cannabis dependence in adolescents : A randomised controlled trial in Western European outpatient settings. In: Drug and Alcohol Dependence. 2013 ; Vol. 130, No. 1-3. pp. 85-93.
@article{80f66387c2174c69a6cb6640682acbd3,
title = "Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: A randomised controlled trial in Western European outpatient settings",
abstract = "Background: Noticing a lack of evidence-based programmes for treating adolescents heavily using cannabis in Europe, government representatives from Belgium, France, Germany, The Netherlands, and Switzerland decided to have U.S.-developed multidimensional family therapy (MDFT) tested in their countries in a trans-national trial, called the International Need for Cannabis Treatment (INCANT) study. Methods: INCANT was a 2 (treatment condition) × 5 (time) repeated measures intent-to-treat randomised effectiveness trial comparing MDFT to Individual Psychotherapy (IP). Data were gathered at baseline and 3, 6, 9 and 12 months thereafter. Study participants were recruited at outpatient secondary level addiction, youth, and forensic care clinics in Brussels, Berlin, Paris, The Hague, and Geneva. Participants were adolescents from 13 through 18 years of age with a recent cannabis use disorder. 85{\%} were boys; 40{\%} were of foreign descent. One-third had been arrested for a criminal offence in the past 3 months. Three primary outcomes were assessed: (1) treatment retention, (2) prevalence of cannabis use disorder and (3) 90-day frequency of cannabis consumption. Results: Positive outcomes were found in both the MDFT and IP conditions. MDFT outperformed IP on the measures of treatment retention (p<0.001) and prevalence of cannabis dependence (p=0.015). MDFT reduced the number of cannabis consumption days more than IP in a subgroup of adolescents reporting more frequent cannabis use (p=0.002). Conclusions: Cannabis use disorder was responsive to treatment. MDFT exceeded IP in decreasing the prevalence of cannabis dependence. MDFT is applicable in Western European outpatient settings, and may show moderately greater benefits than IP in youth with more severe substance use.",
keywords = "Adolescents, Cannabis dependence, Multi-site treatment trial, Multidimensional family therapy, Treatment retention",
author = "Henk Rigter and Henderson, {Craig E.} and Isidore Pelc and Peter Tossmann and Olivier Phan and Vincent Hendriks and Michael Schaub and Rowe, {Cynthia L}",
year = "2013",
month = "6",
day = "1",
doi = "10.1016/j.drugalcdep.2012.10.013",
language = "English",
volume = "130",
pages = "85--93",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Multidimensional family therapy lowers the rate of cannabis dependence in adolescents

T2 - A randomised controlled trial in Western European outpatient settings

AU - Rigter, Henk

AU - Henderson, Craig E.

AU - Pelc, Isidore

AU - Tossmann, Peter

AU - Phan, Olivier

AU - Hendriks, Vincent

AU - Schaub, Michael

AU - Rowe, Cynthia L

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background: Noticing a lack of evidence-based programmes for treating adolescents heavily using cannabis in Europe, government representatives from Belgium, France, Germany, The Netherlands, and Switzerland decided to have U.S.-developed multidimensional family therapy (MDFT) tested in their countries in a trans-national trial, called the International Need for Cannabis Treatment (INCANT) study. Methods: INCANT was a 2 (treatment condition) × 5 (time) repeated measures intent-to-treat randomised effectiveness trial comparing MDFT to Individual Psychotherapy (IP). Data were gathered at baseline and 3, 6, 9 and 12 months thereafter. Study participants were recruited at outpatient secondary level addiction, youth, and forensic care clinics in Brussels, Berlin, Paris, The Hague, and Geneva. Participants were adolescents from 13 through 18 years of age with a recent cannabis use disorder. 85% were boys; 40% were of foreign descent. One-third had been arrested for a criminal offence in the past 3 months. Three primary outcomes were assessed: (1) treatment retention, (2) prevalence of cannabis use disorder and (3) 90-day frequency of cannabis consumption. Results: Positive outcomes were found in both the MDFT and IP conditions. MDFT outperformed IP on the measures of treatment retention (p<0.001) and prevalence of cannabis dependence (p=0.015). MDFT reduced the number of cannabis consumption days more than IP in a subgroup of adolescents reporting more frequent cannabis use (p=0.002). Conclusions: Cannabis use disorder was responsive to treatment. MDFT exceeded IP in decreasing the prevalence of cannabis dependence. MDFT is applicable in Western European outpatient settings, and may show moderately greater benefits than IP in youth with more severe substance use.

AB - Background: Noticing a lack of evidence-based programmes for treating adolescents heavily using cannabis in Europe, government representatives from Belgium, France, Germany, The Netherlands, and Switzerland decided to have U.S.-developed multidimensional family therapy (MDFT) tested in their countries in a trans-national trial, called the International Need for Cannabis Treatment (INCANT) study. Methods: INCANT was a 2 (treatment condition) × 5 (time) repeated measures intent-to-treat randomised effectiveness trial comparing MDFT to Individual Psychotherapy (IP). Data were gathered at baseline and 3, 6, 9 and 12 months thereafter. Study participants were recruited at outpatient secondary level addiction, youth, and forensic care clinics in Brussels, Berlin, Paris, The Hague, and Geneva. Participants were adolescents from 13 through 18 years of age with a recent cannabis use disorder. 85% were boys; 40% were of foreign descent. One-third had been arrested for a criminal offence in the past 3 months. Three primary outcomes were assessed: (1) treatment retention, (2) prevalence of cannabis use disorder and (3) 90-day frequency of cannabis consumption. Results: Positive outcomes were found in both the MDFT and IP conditions. MDFT outperformed IP on the measures of treatment retention (p<0.001) and prevalence of cannabis dependence (p=0.015). MDFT reduced the number of cannabis consumption days more than IP in a subgroup of adolescents reporting more frequent cannabis use (p=0.002). Conclusions: Cannabis use disorder was responsive to treatment. MDFT exceeded IP in decreasing the prevalence of cannabis dependence. MDFT is applicable in Western European outpatient settings, and may show moderately greater benefits than IP in youth with more severe substance use.

KW - Adolescents

KW - Cannabis dependence

KW - Multi-site treatment trial

KW - Multidimensional family therapy

KW - Treatment retention

UR - http://www.scopus.com/inward/record.url?scp=84877078566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877078566&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2012.10.013

DO - 10.1016/j.drugalcdep.2012.10.013

M3 - Article

C2 - 23140805

AN - SCOPUS:84877078566

VL - 130

SP - 85

EP - 93

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-3

ER -